Pediatric unrelated cord blood transplant results
Investigator . | No. patients . | Diseases . | Median follow-up time, mo . | Disease-free survival, % . |
---|---|---|---|---|
Kurtzberg et al33 | 25 | ALL, AML, MDS, Fanconi, metabolic, other | 13 | 48 |
Locatelli et al31 | 60 | ALL, AML | 14 | 34 |
Gluckman et al40 | 65* | ALL, AML, MDS, CML, lymphoma, Fanconi, metabolic disorders, other | 10 | 29 |
Wagner et al36 | 102 | AML, ALL, CML, lymphoma, Fanconi, metabolic disorders, other | 32 | 47 |
Michel et al35 | 95 | AML | 31 | 41 |
Staba et al39 | 20 | Hurler syndrome | 30 | 85 |
Investigator . | No. patients . | Diseases . | Median follow-up time, mo . | Disease-free survival, % . |
---|---|---|---|---|
Kurtzberg et al33 | 25 | ALL, AML, MDS, Fanconi, metabolic, other | 13 | 48 |
Locatelli et al31 | 60 | ALL, AML | 14 | 34 |
Gluckman et al40 | 65* | ALL, AML, MDS, CML, lymphoma, Fanconi, metabolic disorders, other | 10 | 29 |
Wagner et al36 | 102 | AML, ALL, CML, lymphoma, Fanconi, metabolic disorders, other | 32 | 47 |
Michel et al35 | 95 | AML | 31 | 41 |
Staba et al39 | 20 | Hurler syndrome | 30 | 85 |
ALL indicates acute lymphocytic leukemia; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia.
20 patients under age 20